Amethis

Investment to drive innovation and help expand access to specialty drugs across Africa Marcyrl Pharmaceutical Industries (“Marcyrl”), a leading Egyptian pharmaceuticals manufacturer focused on specialty generics, today announced a new investment aimed at accelerating its ambition to drive greater access to critical care drugs across Africa. The significant minority investment from Development Partners International (“DPI”) […]

...